Loading people...
Karen Kerr is the Founder and Managing Director of Exposition Ventures, an early-stage venture capital firm based in Chicago, Illinois. Before establishing the firm in 2019, she served as the Executive Managing Director at GE Ventures, where she directed corporate venture capital strategies and investments for the Fortune 500 industrial conglomerate. Her earlier career includes roles as Senior Director of New Ventures at the University of Chicago and Managing Director at ARCH Venture Partners. She holds a PhD in Physical Chemistry from the University of Chicago and an AB in Chemistry from Bryn Mawr College, and she currently serves on the board of directors for mHUB, a prominent hardtech innovation center. Today, Kerr focuses her early-stage investment strategy on commercializing complex scientific research and scaling hardware companies within the deep tech, advanced manufacturing, and industrial software sectors.
Karen Kerr is a distinguished Managing Director at GE Ventures, a leading corporate venture capital arm known for investing in groundbreaking technologies and businesses. In her pivotal role, Ms. Kerr is instrumental in identifying, evaluating, and investing in early to growth stage companies that are poised to revolutionize the healthcare and life sciences industries. Her expertise spans a broad spectrum, including digital health solutions, precision medicine, advanced diagnostics, medical devices, and the application of artificial intelligence in healthcare.
At GE Ventures, Karen Kerr's work is deeply integrated with GE's broader strategic objectives, aiming to foster innovation that complements and expands GE's core businesses. She is known for her ability to forge strategic partnerships between portfolio companies and GE's vast industrial ecosystem, thereby accelerating market adoption and creating significant value. Her investment philosophy emphasizes not just financial returns, but also strategic alignment and the potential for transformative impact on patient care and industrial efficiency.
Prior to her tenure at GE Ventures, Karen Kerr built an impressive career marked by leadership roles in venture capital and corporate development. This extensive background has equipped her with a profound understanding of technology commercialization, market dynamics, and the intricacies of scaling innovative enterprises. Her experience has been vital in navigating complex investment landscapes and identifying high-potential opportunities across various technology sectors. She brings a wealth of knowledge in nurturing startups from concept to market leadership, leveraging her strategic insights and operational acumen.
While specific individual investments are often part of a broader fund strategy, Karen Kerr's leadership has been central to GE Ventures' successful portfolio in areas like digital health platforms that enhance clinical workflows, AI-powered diagnostic tools improving accuracy, and novel therapeutic approaches. Her contributions have helped position GE Ventures as a key player in fostering the next generation of healthcare and industrial technology leaders, driving forward solutions that address some of the world's most pressing challenges in health and industry.
Karen Kerr's commitment to innovation extends beyond capital deployment; she is a strong advocate for entrepreneurs and a mentor to many, helping to shape the future of technology and healthcare through strategic guidance and active engagement.
Karen Kerr is a Managing Director at GE Ventures, specializing in strategic investments within the healthcare and life sciences sectors. She plays a key role in identifying and supporting innovative companies.
Karen Kerr invests in companies focused on digital health, precision medicine, advanced diagnostics, medical devices, and the application of artificial intelligence in healthcare and life sciences.
Karen Kerr works as a Managing Director at GE Ventures, the corporate venture capital arm of General Electric.
